| Identification | Back Directory | [Name]
Spiro[cyclopentane-1,7'(8'H)-[3H]imidazo[2,1-b]purin]-4'(5'H)-one, 2'-([1,1'-biphenyl]-4-ylmethyl)-5'-methyl-3'-(phenylmethyl)- | [CAS]
191982-37-3 | [Synonyms]
Spiro[cyclopentane-1,7'(8'H)-[3H]imidazo[2,1-b]purin]-4'(5'H)-one, 2'-([1,1'-biphenyl]-4-ylmethyl)-5'-methyl-3'-(phenylmethyl)- | [Molecular Formula]
C32H31N5O | [MOL File]
191982-37-3.mol | [Molecular Weight]
501.62 |
| Hazard Information | Back Directory | [Description]
PDE1-IN-1can enhance levels of the second messengers cAMP/cGMP leading to the expression of neuronal plasticity-related genes, neurotrophic factors, and neuroprotective molecules. These neuronal plasticity enhancement properties make PDE1 inhibitors good candidates as therapeutic agents in many neurological conditions. |
|
|